본문 바로가기
KERD
논문KCI 등재

Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology

박민정|권민수|박현선
대한배뇨장애요실금학회 (Korean Continence Society)|2016.11|International Neurourology Journal|제20권 제1호|pp. 8-14

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

ImmunotherapyT CellNeuroimmunologyNeurological DisordersNeurogenic Bladder Dysfunction

초록

Previous concepts of immune-privileged sites obscured the role of peripheral immune cells in neurological disorders and excluded the consideration of the potential benefits of immunotherapy. Recently, however, numerous studies have demonstrated that the blood–brain barrier in the central nervous system is an educational barrier rather than an absolute barrier to peripheral immune cells. Emerging knowledge of immune-privileged sites suggests that peripheral immune cells can infiltrate these sites via educative gates and that crosstalk can occur between infiltrating immune cells and the central nervous system parenchyma. This concept can be expanded to the testis, which has long been considered an immune-privileged site, and to neurogenic bladder dysfunction. Thus, we propose that the relationship between peripheral immune cells, the brain, and the urologic system should be considered as an additional possible mechanism in urologic diseases, and that immunotherapy might be an alternative therapeutic strategy in treating neurogenic bladder dysfunction.

Abstract

Previous concepts of immune-privileged sites obscured the role of peripheral immune cells in neurological disorders and excluded the consideration of the potential benefits of immunotherapy. Recently, however, numerous studies have demonstrated that the blood–brain barrier in the central nervous system is an educational barrier rather than an absolute barrier to peripheral immune cells. Emerging knowledge of immune-privileged sites suggests that peripheral immune cells can infiltrate these sites via educative gates and that crosstalk can occur between infiltrating immune cells and the central nervous system parenchyma. This concept can be expanded to the testis, which has long been considered an immune-privileged site, and to neurogenic bladder dysfunction. Thus, we propose that the relationship between peripheral immune cells, the brain, and the urologic system should be considered as an additional possible mechanism in urologic diseases, and that immunotherapy might be an alternative therapeutic strategy in treating neurogenic bladder dysfunction.

참고문헌 (57)

  1. Medawar PB, "Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye", Br J Exp Pathol, 29, pp.58~69 (1948)
  2. Shechter R, "Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates", Nat Rev Immunol, 13, pp.206~218 (2013)
  3. Trapp BD, "Multiple sclerosis: an immune or neurodegenerative disorder?", Annu Rev Neurosci, 31, pp.247~269 (2008)
  4. Engelhardt B, "Capture, crawl, cross: the T cell code to breach the blood-brain barriers", Trends Immunol, 33, pp.579~589 (2012)
  5. Mortazavi MM, "The choroid plexus: a comprehensive review of its history, anatomy, function, histology, embryology, and surgical considerations", Childs Nerv Syst, 30, pp.205~214 (2014)
  6. Carrithers MD, "Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment", Brain, 123(Pt 6), pp.1092~1101 (2000)
  7. Provencio JJ, "Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients", J Neuroimmunol, 163, pp.179~184 (2005)
  8. Kivisäkk P, "T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking", Clin Exp Immunol, 129, pp.510~518 (2002)
  9. Baruch K, "Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function", Science, 346, pp.89~93 (2014)
  10. Castellano JM, "Blood-borne revitalization of the aged brain", JAMA Neurol, 72, pp.1191~1194 (2015)
  11. Villeda SA, "Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice", Nat Med, 20, pp.659~663 (2014)
  12. Mawuenyega KG, "Decreased clearance of CNS beta-amyloid in Alzheimer’s disease", Science, 330, pp.1774~ (2010)
  13. Ransohoff RM, "Microglial physiology: unique stimuli, specialized responses", Annu Rev Immunol, 27, pp.119~145 (2009)
  14. Michaud JP, "Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta", Cell Rep, 5, pp.646~653 (2013)
  15. Dauer W, "Parkinson’s disease: mechanisms and models", Neuron, 39, pp.889~909 (2003)
  16. Spillantini MG, "Alpha-synuclein in Lewy bodies", Nature, 388, pp.839~840 (1997)
  17. Appel SH, "T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening?", Trends Immunol, 31, pp.17~ (2010)
  18. Benner EJ, "Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons", PLoS One, 3, pp.e1376~ (2008)
  19. Brochard V, "Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease", J Clin Invest, 119, pp.182~192 (2009)
  20. Benner EJ, "Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease", Proc Natl Acad Sci U S A, 101, pp.9435~9440 (2004)
  21. Kipnis J, "Neuroprotective autoimmunity: naturally occurring CD4+CD25+regulatory T cells suppress the ability to withstand injury to the central nervous system", Proc Natl Acad Sci U S A, 99, pp.15620~15625 (2002)
  22. -synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets, "J Immunol", 2009, 4137~4149
  23. Reynolds AD, "Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease", J Leukoc Biol, 82, pp.1083~1094 (2007)
  24. Kiernan MC, "Amyotrophic lateral sclerosis", Lancet, 377, pp.942~955 (2011)
  25. Gordon PH, "How can we improve clinical trials in amyotrophic lateral sclerosis?", Nat Rev Neurol, 7, pp.650~654 (2011)
  26. Oh KW, "Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis", Stem Cells Transl Med, 4, pp.590~597 (2015)
  27. Philips T, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease", Lancet Neurol, 10, pp.253~263 (2011)
  28. Paez-Colasante X, "Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era", Nat Rev Neurol, 11, pp.266~279 (2015)
  29. Robberecht W, "The changing scene of amyotrophic lateral sclerosis", Nat Rev Neurosci, 14, pp.248~264 (2013)
  30. Henkel JS, "Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival", EMBO Mol Me, 5, pp.64~79 (2013)
  31. Beers DR, "Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis", Brain, 134(Pt 5), pp.1293~1314 (2011)
  32. Zhao W, "Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis", J Neuroimmune Pharmacol, 8, pp.888~899 (2013)
  33. Kwon MS, "The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients", J Neurochem, 131, pp.206~218 (2014)
  34. Belmaker RH, "Major depressive disorder", N Engl J Med, 358, pp.55~68 (2008)
  35. Melfi CA, "The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression", Arch Gen Psychiatry, 55, pp.1128~1132 (1998)
  36. Teasdale JD, "Prevention of relapse", recurrence in major depression by mindfulness-based cognitive therapy, 2000, pp.68, 615~623
  37. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
  38. Carvalho LA, "Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system", J Affect Disord, 148, pp.136~140 (2013)
  39. Hodes GE, "Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress", Proc Natl Acad Sci U S A, 111, pp.16136~16141 (2014)
  40. Han A, "IL-4", 10prevents stress vulnerability following imipramine discontinuation, 2015, pp.12, 197~
  41. Dantzer R, "Inflammationassociated depression: from serotonin to kynurenine", Psychoneuroendocrinology, 36, pp.426~436 (2011)
  42. Yirmiya R, "Depression as a microglial disease", Trends Neurosci, 38, pp.637~658 (2015)
  43. Wake H, "Microglia: actively surveying and shaping neuronal circuit structure and function", Trends Neurosci, 36, pp.209~217 (2013)
  44. Saijo K, "Microglial cell origin and phenotypes in health and disease", Nat Rev Immunol, 11, pp.775~787 (2011)
  45. Mitchell KJ, "Rethinking the genetic architecture of schizophrenia", Psychol Med, 41, pp.19~32 (2011)
  46. Upthegrove R, "Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis", Schizophr Res, 155, pp.101~108 (2014)
  47. Miller BJ, "Metaanalysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects", Biol Psychiatry, 70, pp.663~671 (2011)
  48. Crystal C. Watkins, "Clinical studies of neuroinflammatory mechanisms in schizophrenia", Schizophrenia Research, 176(1), pp.14~22 (2016), Elsevier BV[DOI]
  49. Khandaker GM, "Is there a role for immune-to-brain communication in schizophrenia?", Psychopharmacology (Berl), 233, pp.1559~1573 (2016)
  50. Durrenberger PF, "Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study", J Neural Transm (Vienna), 122, pp.1055~1068 (2015)
  51. Herberth M, "Identification of a molecular profile associated with immune status in first-onset schizophrenia patients", Clin Schizophr Relat Psychoses, 7, pp.207~215 (2014)
  52. Busse S, "Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia:further evidence for disease course-related immune alterations?", Brain Behav Immun, 26, pp.1273~1279 (2012)
  53. Debnath M, "Adaptive Immunity in schizophrenia: functional implications of t cells in the etiology, course and treatment", J Neuroimmune Pharmacol, 10, pp.610~619 (2015)
  54. Naito M, "The presence of intra-tubular lymphocytes in normal testis of the mouse", Okajimas Folia Anat Jpn, 85, pp.91~96 (2008)
  55. Goyal HO, "The rete testis of the goat, a morphological study", Acta Anat (Basel), 130, pp.151~157 (1987)
  56. Soler R, "Development of bladder dysfunction in a rat model of dopaminergic brain lesion", Neurourol Urodyn, 30, pp.188~193 (2011)
  57. Cho YS, "A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction: Analysis of lower urinary tract function", Mol Med Rep, 12, pp.2563~2569 (2015)

관련 논문AI추천

The blood cerebrospinal fluid barrier orchestrates immunosurveillance, immunoprotection, and immunopathology in the central nervous system배재성, 진희경, AYUB MARIA생화학분자생물학회 · BMB Reports2021 · 제54권 제4호Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging TherapiesCarlo Gandi, PierFrancesco Bassi, Riccardo Bientinesi대한배뇨장애요실금학회 · International Neurourology Journal2020 · 제24권 제2호Autonomic dysfunction in multiple sclerosis and neuromyelitis optica spectrum disorderJu-Hong Min, Soonwook Kwon대한임상신경생리학회 · Annals of Clinical Neurophysiology2023 · 제25권 제1호The Innovative Approach in Functional Bladder Disorders: The Communication Between Bladder and Brain-Gut Axis김아람, 양승훈, 정지원대한배뇨장애요실금학회 · International Neurourology Journal2023 · 제27권 제1호The role of neuroinflammation on the pathogenesis of Parkinson’s disease고혁완, 남진한, 복유진, 정영철, 진병관, 허수희생화학분자생물학회 · BMB Reports2010 · 제43권 제4호Potential Mechanisms Underlying the Increased Excitability of the Bladder Afferent Pathways in Interstitial Cystitis/Bladder Pain Syndrome김두상대한요로생식기감염학회 · Urogenital Tract Infection2018 · 제13권 제2호

이 간행물의 다른 논문 (24건)

Learning From Heart Failure: How Will We Lead Bladder Failure Into the Future?권휘안, 이택pp. 1-2New Horizon for Neurourological Research김계환pp. 1-1Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders김병선, 홍희옥, 임혜인pp. 2-7Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery조영삼pp. 3-4Rescue of Heart Failure by Mitochondrial RecoveryJubert Marquez, 이성률, 김나리, 한진pp. 5-12
원문 보기